Phase 2 Vestibular Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 2

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Neurofibromatosis type 2MeningiomaEpendymoma+2 more

Scott R. Plotkin, MD, PhD109 enrolled6 locationsNCT04374305

Recruiting

Phase 1Phase 2

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Vestibular Schwannoma

Akouos, Inc.27 enrolled4 locationsNCT06517888

Not Yet Recruiting

Phase 2Phase 3

Pregabalin for the treatment of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) associated chronic cough.

Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)chronic cough

Richard Roxburgh18 enrolled1 locationACTRN12623001356651

Terminated

Phase 2

Clinical trial of a take-home rehabilitation device for vestibular patients.

Reduced vestibulo-ocular reflex response (due to peripheral vestibular dysfunction only).

Neuroscience Research Australia60 enrolled1 locationACTRN12615000392561